CEPHARANTHINE

/static/temp/default.svg Search structure
Status
Molecule Category Free-form

Structure

InChI Key YVPXVXANRNDGTA-WDYNHAJCSA-N
Smiles COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3c(cc4c(c3Oc3cc5c(cc3OC)CCN(C)[C@@H]5C2)OCO4)CCN1C
InChI
InChI=1S/C37H38N2O6/c1-38-13-11-24-18-31(41-4)33-20-27(24)28(38)16-23-7-10-30(40-3)32(17-23)44-26-8-5-22(6-9-26)15-29-35-25(12-14-39(29)2)19-34-36(37(35)45-33)43-21-42-34/h5-10,17-20,28-29H,11-16,21H2,1-4H3/t28-,29+/m1/s1

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Hydrolase
- - - - 8.59-40.58
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC21/SLCO family of organic anion transporting polypeptides
- - - - 91.94-125.11
Transporter Primary active transporter ATP-binding cassette ABCC subfamily
- - - - 20
EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Cricetulus griseus
- - - - 91.94-125.11
Electrophorus electricus
- - - - 8.59
Equus caballus
- - - - 40.58
Homo sapiens
- - - - 20
Mus musculus
- - - - 34-85
Plasmodium falciparum
- 478-610 - - -
Plasmodium falciparum D6
- 231 - - -
CONTENTS